ARM-101

N/A

Report date: 2026/05/22 14:57:12

Base Information

Drug NameARM-101
Drug Alias NameARM-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionPeripheral myelin protein 22 inhibitors
TargetsPeripheral myelin protein 22
Therapy Area/IndicationsCharcot-Marie-Tooth Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArmatus Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesArmatus Bio Inc
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A